Sunshine Biopharma, Inc. (SBFM)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 6.08M |
| Enterprise Value | -9.56M |
| Trailing P/E | 1.21 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.06 |
| Price/Book (mrq) | 0.29 |
| Enterprise Value/Revenue | -0.40 |
| Enterprise Value/EBITDA | 2.50 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | -1.11 |
| 52-Week Change 3 | -91.02% |
| S&P500 52-Week Change 3 | 21.83% |
| 52 Week High 3 | 1.4000 |
| 52 Week Low 3 | 0.0439 |
| 50-Day Moving Average 3 | 0.0826 |
| 200-Day Moving Average 3 | 0.2756 |
Share Statistics
| Avg Vol (3 month) 3 | 23.42M |
| Avg Vol (10 day) 3 | 16.76M |
| Shares Outstanding 5 | 99.45M |
| Implied Shares Outstanding 6 | 130.54M |
| Float 8 | 95.34M |
| % Held by Insiders 1 | 9.45% |
| % Held by Institutions 1 | 6.51% |
| Shares Short (Mar 28, 2024) 4 | 706.7k |
| Short Ratio (Mar 28, 2024) 4 | 0.02 |
| Short % of Float (Mar 28, 2024) 4 | 0.74% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 0.71% |
| Shares Short (prior month Feb 29, 2024) 4 | 445.3k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Apr 06, 2020 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:100 |
| Last Split Date 3 | Apr 17, 2024 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -18.70% |
| Operating Margin (ttm) | -15.46% |
Management Effectiveness
| Return on Assets (ttm) | -10.57% |
| Return on Equity (ttm) | -21.04% |
Income Statement
| Revenue (ttm) | 24.09M |
| Revenue Per Share (ttm) | 0.99 |
| Quarterly Revenue Growth (yoy) | 94.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -4.64M |
| Net Income Avi to Common (ttm) | -4.51M |
| Diluted EPS (ttm) | -0.1900 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.29M |
| Total Cash Per Share (mrq) | 0.16 |
| Total Debt (mrq) | 657.71k |
| Total Debt/Equity (mrq) | 3.10% |
| Current Ratio (mrq) | 4.48 |
| Book Value Per Share (mrq) | 0.76 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8.78M |
| Levered Free Cash Flow (ttm) | -8.2M |
© 2024 Yahoo. All rights reserved.